Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon May 12, 2025 Next Post Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround May 13, 2025 Related Posts Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 6, 2025 Silver Price Surges to US$36, Marking 13 Year High June 6, 2025 Auto Industry Takes Hit as China’s Rare Earths Export Controls Impact Supply Chains June 6, 2025
Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 6, 2025